Company: REVB
Filing Date: 2025-09-12
Form Type: PRE 14A
Source: 0000950170-25-114524
Chunk: 15

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-09-12
Form: PRE 14A
Chunk 15
---
                                            |     |                    |      65 |     |               |    * |   |
| Lakhmir Chawla, M.D.(7)                                  |     |                    |      61 |     |               |    * |   |
| Chester S. Zygmont, III(8)                               |     |                    |   5,031 |     |               |    * |   |
| All Directors and Officers as a Group (Five Individuals) |     |                    |  15,271 |     |               |    * |   |

| * | Less than one percent. |

| (1) | The securities are held by Armistice Capital Master Fund Ltd., (“Armistice Master Fund”), and may be deemed to be beneficially owned by: (i) Armistice Capital, LLC (“Armistice Capital”), as the investment manager of the Armistice Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital. The address of Armistice Capital Master Fund Ltd. is c/o Armistice Capital, LLC, 510 Madison Avenue, 7th Floor, New York, NY 10022. Includes 186,904 shares of common stock with the right to acquire within 60 days. |

| (2) | Unless otherwise indicated, the business address of each of the individuals is c/o Revelation Biosciences, Inc., 4660 La Jolla Village Dr., Suite 100, San Diego, CA 92122. |

| (3) | Consists of (i) 10,046 shares of common stock held directly by Mr. Rolke, and (ii) 1 shares of common stock underlying Stock Options exercisable within 60 days by Mr. Rolke. |

| (5) | Consists of (i) 63 shares of common stock held directly by Ms. Carver and (ii) 4 shares of common stock underlying Stock Options exercisable within 60 days by Ms. Carver. |

| (6) | Consists of (i) 61 shares of common stock held directly by Mr. Roper and (ii) 4 shares of common stock underlying Stock Options exercisable within 60 days by Mr. Roper. |

| (7) | Consists of 61 shares of common stock held directly by Dr. Chawla. |

| (8) | Consists of (i) 5,026 shares of common stock held by The